Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 6, 2011, Pages 2228-2233

  Akutsu, Masato ^a   Ye, Yu ^a   Virdee, Satpal ^a   Chin, Jason W ^a   Komander, David ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Biochemistry; Cell signaling; Emerging disease; Structural biology

Indexed keywords

ISG15 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS OVARIAN TUMOR PROTEIN DOMAIN DEUBIQUITINASE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; CROSS REACTION; CRYSTAL STRUCTURE; ENZYME ACTIVITY; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS;

CYTOKINES; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HUMANS; OVARIAN NEOPLASMS; PEPTIDE HYDROLASES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; UBIQUITIN; UBIQUITINATION; UBIQUITINS; VIRAL PROTEINS;

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; EUKARYOTA;

EID: 79952301200     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1015287108     Document Type: Article

References (28)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801. (Pubitemid 43261452)
2. O'Neill LA, Bowie AG (2010) Sensing and signaling in antiviral innate immunity. Curr Biol 20:R328-333.
3. Sadler AJ, Williams BRG (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8:559-568. (Pubitemid 351913674)
4. Komander D (2009) The emerging complexity of protein ubiquitination. Biochem Soc Trans 37:937-953.
5. Zeng W, et al. (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-330.
6. Skaug B, Jiang X, Chen ZJ (2009) The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 78:769-796.
7. Tokunaga F, et al. (2009) Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat Cell Biol 11:123-132.
8. Komander D, Clague MJ, Urbé S (2009) Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10:550-563.
9. Wertz I, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694-699.
10. Kayagaki N, et al. (2007) DUBA: A deubiquitinase that regulates type I interferon production. Science 318:1628-1632. (Pubitemid 350233662)
11. Dao CT, Zhang DE (2005) ISG15: A ubiquitin-like enigma. Front Biosci 10:2701-2722. (Pubitemid 40905270)
12. Narasimhan J, et al. (2005) Crystal structure of the interferon-induced ubiquitin-like protein ISG15. J Biol Chem 280:27356-27365. (Pubitemid 41040777)
13. Skaug B, Chen ZJ (2010) Emerging role of ISG15 in antiviral immunity. Cell 143:187-190.
14. Durfee LA, Lyon N, Seo K, Huibregtse JM (2010) The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell 38:722-732.
15. Randow F, Lehner PJ (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11:527-534.
16. Frias-Staheli N, et al. (2007) Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2:404-416. (Pubitemid 350225347)
17. Weber F, Mirazimi A (2008) Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth F R 19:395-404.
18. Bremm A, Freund SM, Komander D (2010) Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat Struct Mol Biol 17:939-947.
19. Virdee S, Ye Y, Nguyen DP, Komander D, Chin JW (2010) Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. Nat Chem Biol 6:750-757.
20. Komander D, et al. (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10:466-473.
21. Edelmann MJ, et al. (2009) Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 418:379-390.
22. Xia Z-P, et al. (2009) Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461:114-119.
23. Messick TE, et al. (2008) Structural basis for ubiquitin recognition by the Otu1 ovarian tumor domain protein. J Biol Chem 283:11038-11049.
24. Borodovsky A, et al. (2002) Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol 9:1149-1159. (Pubitemid 35240937)
25. Ziebuhr J, Snijder EJ, Gorbalenya AE (2000) Virus-encoded proteinases and proteolytic processing inthe Nidovirales. J Gen Virol 81:853-879. (Pubitemid 30189624)
26. Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE (2002) UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277:9976-9981. (Pubitemid 34968105)
27. Lindner HA, et al. (2007) Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch Biochem Biophys 466:8-14. (Pubitemid 47405070)
28. Bergeron E, Albarino CG, Khristova ML, Nichol ST (2009) Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J Virol 84:216-226.